AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30782991
Drug: Concomitant CQ-PQ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant CQ-PQ treatment (arm 2)
Trial: 11439794
Drug: Morphine 1
RxNorm normalized name: morphine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 1 mg/ml (group M)
Trial: 11439794
Drug: Morphine 1
RxNorm normalized name: morphine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 1 mg/ml plus ketamine 2 mg/ml (group K)
Trial: 9492501
Drug: Bolus injection
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus injection of buprenorphine 0.1-0.2 mg with 0.25% bupivacaine
Trial: 9492501
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of buprenorphine 0.4 mg with 0.25% bupivacaine (40 ml at 1.7 ml.h-1)
Trial: 3128112
Drug: Cefoxitin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoxitin (3 doses of 2 gm: first 30-60 min before operation, then 6 and 12 hours later)
Trial: 30690679
Drug: Fluoroscopy-guided intraarticular
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoroscopy-guided intraarticular shoulder injection (IAI)
Trial: 24482140
Drug: Traditional analytic
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional analytic measures (e.g., participation rate, representativeness)
Trial: 21714686
Drug: Genistein (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genistein (30 mg daily)
Trial: 9048269
Drug: Methylnaltrexone 0.64
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylnaltrexone 0.64 mg/kg
Trial: 9048269
Drug: Methylnaltrexone 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylnaltrexone 1.25 mg/kg
Trial: 9048269
Drug: Methylnaltrexone 0.32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylnaltrexone 0.32 mg/kg
Trial: 8322564
Drug: Intramuscular buprenorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular buprenorphine (4 micrograms.kg‐1 body weight)
Trial: 3524648
Drug: Zaprinast (M&B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zaprinast (M&B 22,948, a single oral dose)
Trial: 31997490
Drug: Control (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (single antiplatelet therapy)
Trial: 29502273
Drug: High-dose flavanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose flavanol
Trial: 29502273
Drug: Low-dose flavanol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose flavanol
Trial: 12835884
Drug: Disodium pamidronate
RxNorm normalized name: Disodium pamidronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disodium pamidronate (DP) 90 to 180 mg (stepwise increase) plus radiotherapy (30 Gy in ten fractions)
Trial: 12835884
Drug: Disodium pamidronate
RxNorm normalized name: Disodium pamidronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disodium pamidronate (DP) 180 mg (flat dose) plus radiotherapy (30 Gy in ten fractions)
Trial: 10680442
Drug: Flutrimazole 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutrimazole 1% cream
Trial: 1726411
Drug: Selenium supplementation
RxNorm normalized name: Selenium supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium supplementation in the form of Se-yeast (200 micrograms daily) for 4 years
Trial: 1726411
Drug: Selenium supplementation
RxNorm normalized name: Selenium supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium supplementation in the form of Se-yeast (200 micrograms daily) for 2 years
Trial: 7254893
Drug: Specific therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific therapy
Trial: 25432966
Drug: Probiotics treatment
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics treatment
Trial: 22240593
Drug: Carvedilol CR
RxNorm normalized name: Carvedilol
DrugBank: Carvedilol (DB01136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carvedilol CR (10-80 mg/day)
Trial: 22240593
Drug: Carvedilol CR
RxNorm normalized name: Carvedilol
DrugBank: Carvedilol (DB01136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carvedilol CR (80 mg/day)
Trial: 22240593
Drug: Carvedilol IR
RxNorm normalized name: Carvedilol
DrugBank: Carvedilol (DB01136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carvedilol IR (5-20 mg/day)
Trial: 17544156
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg IV dexamethasone (n=50)
Trial: 8477913
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg quinine HCl
Trial: 8477913
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg quinine HCl
Trial: 8477913
Drug: 160 mg
RxNorm normalized name: nadolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg quinine HCl
Trial: 7031187
Drug: Propranolol (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (120 mg)
Trial: 23733756
Drug: Acetyl-L-carnitine (ALC)
RxNorm normalized name: acetyl-L-carnitine
DrugBank: Acetylcarnitine (DB08842)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-L-carnitine (ALC) 3,000 mg per day
Trial: 12828985
Drug: 0.05M lactic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05M lactic acid gel (6% w/v hydroxyethyl cellulose, pH 4.5) with fluoride for 7 days
Trial: 12828985
Drug: 0.05M lactic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05M lactic acid gel (6% w/v hydroxyethyl cellulose, pH 4.5) without fluoride for 7 days
Trial: 8880847
Drug: Ibuprofen 200
RxNorm normalized name: ibuprofen 200 MG
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen 200 mg plus 50, 100 or 200 mg of caffeine
Trial: 1719654
Drug: Iloprost (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iloprost (maximum tolerated dose up to 2 ng/kg/min, administered as a six-hourly intravenous infusion for two to four weeks)
Trial: 12839217
Drug: Fegan's technique
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fegan's technique using a combination of Aethoxysclerol and Fibrovein
Trial: 8669574
Drug: Traditional training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional training group (performed ten nasendoscopies on anaesthetised oral surgery inpatients)
Trial: 6364334
Drug: Metronidazole 2000
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metronidazole 2000 mg in a single dose
Trial: 6364334
Drug: Metronidazole 400
RxNorm normalized name: metronidazole 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole 400 mg three times daily for 5 days
Trial: 31854293
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment (42% of patients)
Trial: 31854293
Drug: Guideline-recommended therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guideline-recommended therapy (58% of patients)
Trial: 31854293
Drug: High mean
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High mean systolic blood pressure after blood pressure-lowering therapy
Trial: 24807329
Drug: Topical aqueous
RxNorm normalized name: Pen-Aqueous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical aqueous 4% lidocaine
Trial: 21988083
Drug: Cognitive stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive stimulation intervention (daily nurse-led, individual-based activities)
Trial: 20329606
Drug: Qingshen Granule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qingshen Granule (QSG), 1 bag thrice a day by oral intake for 1 month
Trial: 20329606
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (conventional Western medical therapy + retention enema of Jiedu Xiezhuo No. II)
Trial: 16275213
Drug: Therapy responders
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapy responders
Trial: 12095880
Drug: Tretinoin cream
RxNorm normalized name: Tretinoin Cream
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tretinoin cream 0.05%
Trial: 10463682
Drug: Thimerosal-preserved vaccine
RxNorm normalized name: Thimerosal
DrugBank: Thimerosal (DB11590)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thimerosal-preserved vaccine
Trial: 10463682
Drug: Autoclaved vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autoclaved vaccine
Trial: 1262709
Drug: Lyophilized vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lyophilized vaccine
Trial: 7607607
Drug: Fructose infusion
RxNorm normalized name: Fructose
DrugBank: Fructose (DB04173)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fructose infusion (15 min iv infusion at 0.185 mmol/kg BW/min)
Trial: 1977761
Drug: Clonidine (0.150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (0.150 mg, orally) followed by GHRH (1 micrograms/kg, iv) at 180 min
Trial: 1977761
Drug: Clonidine (0.150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (0.150 mg, orally) at 0 min followed by GHRH at 60 min and again at 180 min
Trial: 17335818
Drug: Metformin (1,500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (1,500 mg/d)
Trial: 25818049
Drug: 80mg of
RxNorm normalized name: magnesium hydroxide
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 80mg of propranolol hydrochloride (β1 and β2 adrenergic receptor antagonist)
Trial: 25818049
Drug: Microcrystalline cellulose
RxNorm normalized name: Microcrystalline Cellulose
DrugBank: Microcrystalline cellulose (DB14158)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microcrystalline cellulose (placebo pill)
Trial: 15612964
Drug: Zafirlukast, 20
RxNorm normalized name: Zafirlukast, 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zafirlukast, 20 mg bd
Trial: 15612964
Drug: Theophylline, 200
RxNorm normalized name: Theophylline, 200 mg oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline, 200 mg bd
Trial: 12572722
Drug: Ciclopiroxolamine cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciclopiroxolamine cream 11% (group A)
Trial: 12572722
Drug: Ciclopiroxolamine solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciclopiroxolamine solution 1% (group B)
Trial: 9435425
Drug: GH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH treatment (0.125 U/kg per week for 1 month and 0.25 U/kg per week for 5 months)
Trial: 2568817
Drug: Iopromide 370
RxNorm normalized name: IOPROMIDE 370mgI/ml INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iopromide 370 (2 ml/kg body weight)
Trial: 2568817
Drug: Iopamidol 370
RxNorm normalized name: iopamidol 370 mg iodine/mL (76 %) INTRAVEN KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iopamidol 370 (2 ml/kg body weight)
Trial: 2568817
Drug: Sodium meglumine
RxNorm normalized name: Meglumine
DrugBank: Meglumine (DB09415)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium meglumine diatrizoate 370 (2 ml/kg body weight)
Trial: 31604062
Drug: 44 g
RxNorm normalized name: PETROLATUM 44 g in 100 g TOPICAL OINTMENT [Dermaphor]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 44 g (250 kcal) pistachios consumed mid‐morning
Trial: 24106072
Drug: Sildenafil (optimized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (optimized dose)
Trial: 16784743
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine formula
Trial: 15068413
Drug: 1 week
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 1 week of therapy (lansoprazole 30 mg b.i.d., amoxycillin 1 g b.i.d., tinidazole 500 mg b.i.d.)
Trial: 15068413
Drug: 2 weeks
RxNorm normalized name: Rykindo, 25 mg/2 weeks intramuscular powder for injection, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 weeks of therapy (lansoprazole 30 mg b.i.d., amoxycillin 1 g b.i.d., tinidazole 500 mg b.i.d.)
Trial: 15068413
Drug: 3 weeks
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 weeks of therapy (lansoprazole 30 mg b.i.d., amoxycillin 1 g b.i.d., tinidazole 500 mg b.i.d.)
Trial: 1673505
Drug: Moderate alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Moderate alcohol intake (26 g alcohol daily)
Trial: 7181084
Drug: Cimetidine (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (oral and intramuscular)
Trial: 7181084
Drug: Intramuscular Cimetidine
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular Cimetidine
Trial: 25184862
Drug: High-dose melphalan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose melphalan plus stem-cell transplantation
Trial: 22571202
Drug: Lenalidomide maintenance
RxNorm normalized name: Lenalidomide
DrugBank: Lenalidomide (DB00480)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lenalidomide maintenance therapy
Trial: 25184862
Drug: High-dose melphalan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose melphalan
Trial: 22529964
Drug: HIV vaccine
RxNorm normalized name: AAV-2 HIV Vaccine
DrugBank: TGAAC09 (DB06363)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIV vaccine (placebo-controlled trial)
Trial: 2598983
Drug: Intravenous nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous nifedipine (0.75 mg bolus and 1.2 mg.h‐1 infusion for 2 h)
Trial: 2598983
Drug: Oral nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral nifedipine (20 mg sustained-release)
Trial: 2598983
Drug: Vehicle alone
RxNorm normalized name: SUSPENDING VEHICLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle alone (control for intravenous study)
Trial: 2598983
Drug: Placebo (control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (control for oral study)
Trial: 806518
Drug: Enteric-coated lactose
RxNorm normalized name: EC-0652
DrugBank: EC-0652 (DB15340)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric-coated lactose tablets (Control)
Trial: 31010413
Drug: Duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60 mg once-daily (QD)
Trial: 31010413
Drug: Placebo followed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo followed by Duloxetine 60 mg QD (PLA_DLX)
Trial: 31010413
Drug: Duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60 mg QD (DLX_DLX)
Trial: 21163595
Drug: Synthetic genistein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic genistein (30 mg daily)
Trial: 12296616
Drug: Antidepressants, especially
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressants, especially selective serotonin uptake inhibitors
Trial: 12296616
Drug: Early identification
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early identification and treatment
Trial: 9833742
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (zidovudine + 400 mg didanosine + 400 mg nevirapine)
Trial: 9833742
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy (zidovudine + 2.25 mg zalcitabine)
Trial: 9833742
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy (zidovudine alternating monthly with 400 mg didanosine)
Trial: 9833742
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy (zidovudine + 400 mg didanosine)
Trial: 7861603
Drug: Continuous subcutaneous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous subcutaneous administration of 20 micrograms.h‐1 of buprenorphine (Bu) with additional 20 micrograms of Bu using Baxter infusor BB+PCA
Trial: 7861603
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural infusion of 0.4 mg of Bu and 46 ml of 0.25% bupivacaine daily (16.7 micrograms.h‐1 of Bu) using Baxter infusor 2 ml.h‐1 type
Trial: 11791962
Drug: Amodiaquine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amodiaquine (30 and 35 mg/kg body weight)
Trial: 23942868
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg CZP every 2 weeks (Q2W)
Trial: 23942868
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg CZP every 4 weeks (Q4W)
Trial: 21526671
Drug: Propofol administered
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol administered for 30 seconds (Group A)
Trial: 21526671
Drug: Propofol administered
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol administered for 60 seconds (Group B)
Trial: 21526671
Drug: Propofol administered
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol administered for 120 seconds (Group C)
Trial: 18034998
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg renzapride
Trial: 18034998
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg renzapride
Trial: 14872557
Drug: Ritalin LA
RxNorm normalized name: Ritalin LA
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ritalin LA (bimodal release formulation)
Trial: 14872557
Drug: Ritalin IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritalin IR (immediate-release formulation)
Trial: 14872557
Drug: Ritalin LA
RxNorm normalized name: Ritalin LA
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ritalin LA (slow-, medium-, and fast-release formulations)
Trial: 8593718
Drug: Ketoconazole 200
RxNorm normalized name: ketoconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole 200 mg orally + ketoconazole shampoo 2% daily for 4 weeks
Trial: 8593718
Drug: Ketoconazole 200
RxNorm normalized name: ketoconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole 200 mg orally for 4 weeks
Trial: 8593718
Drug: Econazole nitrate
RxNorm normalized name: Econazole Nitrate
DrugBank: Econazole (DB01127)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Econazole nitrate 1% solution applied twice daily for 4 weeks
Trial: 8593718
Drug: Miconazole nitrate
RxNorm normalized name: Miconazole Nitrate
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Miconazole nitrate 2% cream applied twice daily for 4 weeks
Trial: 2678932
Drug: Carbamazepine (CBZ)
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbamazepine (CBZ) with haloperidol (30 mg/day)
Trial: 1502960
Drug: Haloperidol (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (30 mg/day)
Trial: 1090987
Drug: Five drug
RxNorm normalized name: fivehorn smotherweed pollen extract
DrugBank: Bassia hyssopifolia pollen (DB10941)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five drug formulations
Trial: 30753262
Drug: Oral glutamine
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral glutamine (5 g glutamine and 10 g maltodextrin) 3 times daily from 7 days before RT to 14 days after RT
Trial: 30753262
Drug: Placebo (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (15 g maltodextrin) 3 times daily from 7 days before RT to 14 days after RT
Trial: 21919691
Drug: Ruxolitinib (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ruxolitinib (15 or 20 mg twice daily)
Trial: 25907176
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg canagliflozin once-daily (q.d.)
Trial: 25907176
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg canagliflozin once-daily (q.d.)
Trial: 25907176
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg canagliflozin twice-daily (b.i.d.)
Trial: 25907176
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg canagliflozin twice-daily (b.i.d.)
Trial: 25802729
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg canagliflozin
Trial: 25500487
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg canagliflozin